Axel Dignaß

270 papers receiving 17.3k citations

Axel Dignaß's Hit Papers

Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health response 2025 · 19 citations
190+5+10Years since publication50010001.5k

Peers

Axel Dignaß
Comparison fields: 5 of 145
  • Genetics 8.8k
  • Gastroenterology 835
  • Hematology 1.6k
  • Epidemiology 3.5k
  • Immunology 1.9k
Replace Walter Reinisch with:
Walter Reinisch Austria
Sander J. H. van Deventer Netherlands
Stephen B. Hanauer United States
Marc Lémann France
Lloyd Mayer United States
Marc Ferrante Belgium
Julián Panés Spain
Laurent Beaugerie France
Ole Haagen Nielsen Denmark
Claudio Fiocchi United States
Axel Dignaß relative to Walter Reinisch Austria Walter Reinisch's profile →
Citations per field
00.5×1.5×
Walter Reinisch · 1×
Citations per year

Countries citing papers authored by Axel Dignaß

Since Specialization
Citations

This map shows the geographic impact of Axel Dignaß's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Dignaß with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Dignaß more than expected).

Fields of papers citing papers by Axel Dignaß

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axel Dignaß. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Dignaß. The network helps show where Axel Dignaß may publish in the future.

Co-authors

The 25 scholars most cited alongside Axel Dignaß, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Axel Dignaß Line = papers co-authored together Axel Dignaß links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 283 papers — load more, or switch the sort, to bring in the rest.

#Work
1
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
Hit paper breakdown →
20211627
2
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
Hit paper breakdown →
20121252
3
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
Hit paper breakdown →
20101139
4
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis
Hit paper breakdown →
20101046
5
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
Hit paper breakdown →
2017869
6
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial
Hit paper breakdown →
2016755
7
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis
Hit paper breakdown →
2012646
8
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2: Surgical Management and Special Situations
Hit paper breakdown →
2016518
9
European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases
Hit paper breakdown →
2014432
10 1993380
11 2007357
12 2012349
13
Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management
Hit paper breakdown →
2017334
14 2006316
15 2008267
16 2010233
17 1994229
18 2002206
19 2001201
20 2018194

About Axel Dignaß

Axel Dignaß is a scholar working on Genetics, Epidemiology, Surgery, Immunology and Hematology, having authored 283 papers that have together received 17.7k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (159 papers), Microscopic Colitis (71 papers), Eosinophilic Esophagitis (29 papers), Iron Metabolism and Disorders (25 papers), Helicobacter pylori-related gastroenterology studies (16 papers), Biosimilars and Bioanalytical Methods (16 papers), Clinical Nutrition and Gastroenterology (11 papers) and Celiac Disease Research and Management (11 papers). The work is most often cited by research in Genetics (8.8k citations), Gastroenterology (835 citations), Hematology (1.6k citations), Epidemiology (3.5k citations) and Immunology (1.9k citations). Axel Dignaß has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Andreas Sturm, Jürgen M. Stein, Gert Van Assche, Daniel K. Podolsky, Silvio Danese, Simon Travis, Eduard F. Stange, Daniel C. Baumgart, James O. Lindsay and Gerassimos J. Mantzaris. Their work appears in journals such as Journal of Crohn s and Colitis, Gastroenterology, United European Gastroenterology Journal, Inflammatory Bowel Diseases and The American Journal of Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact